Efferocytosis Assay with BMDMs
Corresponding Organization : Albany Medical Center Hospital
Other organizations : Wadsworth Center, New York State Department of Health
Variable analysis
- Treatment of BMDMs with or without 5 μM staurosporine (to induce apoptosis) or LPS (200 ng/ml)+100 μM zVAD (to induce necroptosis) for 24 h
- Efferocytosis of the labeled cells by naïve cells, calculated as a proportion of uptake of labeled cells by quantifying fluorescence intensity using a plate reader
- Monolayers of naïve unlabeled BMDMs
- Vybrant dye (5 μM; Invitrogen, Waltham, MA, USA) used to label the cells
- Positive control: Not explicitly mentioned.
- Negative control: Not explicitly mentioned.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!